Labcorp Holdings (LH) 10-K Summary — Year Ended Dec 31, 2025
Labcorp Holdings Inc. filed its annual report for the most recent fiscal year. The filing describes the company's business, risk factors, financial condition, and liquidity.
Key takeaway
Year ended Dec 31, 2025 · FY2025 10-K
Labcorp Holdings Inc. filed its annual report for the most recent fiscal year. The filing describes the company's business, risk factors, financial condition, and liquidity.
Financial snapshot
Selected annual figures reported with the filing, shown separately from the narrative summary.
Annual revenue
$14B
Revenue reported for the fiscal year.
Operating income
$1.4B
Income from operations reported for the year.
Net income
$876.5M
Net income reported for the year.
Operating cash flow
$1.6B
Cash generated by operating activities.
Annual revenue trend
Reported annual revenue and its change from the preceding fiscal year.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2022 | $11.9B | -9.7% |
| Dec 31, 2023 | $12.2B | +2.5% |
| Dec 31, 2024 | $13B | +7.0% |
| Dec 31, 2025 | $14B | +7.2% |
Business overview
Labcorp is a life sciences company that provides laboratory testing and diagnostic services. The business overview section outlines its operations in clinical laboratory testing and drug development support.
Financial performance
Revenue increased compared to the prior year. Operating income and net income were reported, and operating cash flow was positive.
Material risks
The filing includes a dedicated risk factors section covering potential business, regulatory, and operational uncertainties. Specific unresolved staff comments and cybersecurity matters are also noted.
Liquidity and capital
The company's primary liquidity source is operating cash flow, supplemented by debt offerings. Cash and cash equivalents decreased from the prior year end, driven by investing and financing activities.
What to watch
Monitor changes in operating cash flow trends and working capital timing in the next filing.